Log on / register
Feedback | Support | My details
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ
BMC Cancer 2007, 7:63
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
Rhee J, Han SW, Oh DY, Kim JH, Im SA, Han W, Ae Park I, Noh DY, Bang YJ, Kim TY
BMC Cancer 2008, 8:307 (23 October 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
2.


Research article    
Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer
Nadler Y, Camp RL, Giltnane JM, Moeder C, Rimm DL, Kluger HM, Kluger Y
Breast Cancer Research 2008, 10:R35 (23 April 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 3 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.